14/11/2025
🌍 World Diabetes Day | 14 November
Managing the musculoskeletal and neuropathic complications of diabetes requires effective, safe, and evidence-based therapeutic solutions.
𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐮𝐬𝐢𝐧𝐠 𝐀𝐒𝐀 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 show how Hilterapia® (High Intensity Laser Therapy) and MLS® Laser Therapy can support clinicians in improving pain, function, and tissue repair in patients with diabetes.
🔬 Evidence from clinical research:
1️⃣ 𝐅𝐫𝐨𝐳𝐞𝐧 𝐒𝐡𝐨𝐮𝐥𝐝𝐞𝐫 𝐢𝐧 𝐝𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬: Hilterapia® combined with exercise proved more effective in reducing pain and improving shoulder function compared to ESWT.
𝐻𝑖𝑔ℎ-𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑙𝑎𝑠𝑒𝑟 𝑡ℎ𝑒𝑟𝑎𝑝𝑦 𝑣𝑒𝑟𝑠𝑢𝑠 𝑠ℎ𝑜𝑐𝑘 𝑤𝑎𝑣𝑒 𝑡ℎ𝑒𝑟𝑎𝑝𝑦 𝑖𝑛 𝑡ℎ𝑒 𝑚𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 𝑜𝑓 𝑑𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑓𝑟𝑜𝑧𝑒𝑛 𝑠ℎ𝑜𝑢𝑙𝑑𝑒𝑟
Pharmacophore, 15(2), Pages: 113-118, 2024
2️⃣ 𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐝𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐮𝐥𝐜𝐞𝐫: The MiS device supported complete wound closure within 20 sessions, with stable results at follow-up.
𝐻𝑒𝑎𝑙𝑖𝑛𝑔 𝑜𝑓 𝐿𝑒𝑔 𝐷𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑢𝑙𝑐𝑒𝑟 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑤𝑖𝑡ℎ 𝑀𝐿𝑆-𝑀𝑖𝑆 𝑙𝑎𝑠𝑒𝑟 (𝑀𝑖𝑆 – 𝑀𝐿𝑆® 𝐻𝑖𝑔ℎ 𝑃𝑒𝑎𝑘 𝑃𝑢𝑙𝑠𝑒): 𝑎 𝑐𝑎𝑠𝑒 𝑟𝑒𝑝𝑜𝑟𝑡
Energy For Health [21], 2021
3️⃣ 𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐧𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐢𝐜 𝐩𝐚𝐢𝐧: MLS® Laser Therapy with the M6 device reduced pain by up to −63%, improving sensitivity and nerve function over time.
𝐸𝑓𝑓𝑒𝑐𝑡𝑠 𝑜𝑓 𝑀𝐿𝑆-𝐿𝑎𝑠𝑒𝑟 𝑜𝑛 𝑛𝑒𝑢𝑟𝑜𝑝𝑎𝑡ℎ𝑖𝑐 𝑝𝑎𝑖𝑛 𝑖𝑛 𝑑𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑠𝑒𝑛𝑠𝑜𝑚𝑜𝑡𝑜𝑟 𝑛𝑒𝑢𝑟𝑜𝑝𝑎𝑡ℎ𝑦
Journal of IMAB, Jul-Sep;29(3):5079-5084, 2023
4️⃣ 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐧𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐲: The MiS laser resulted in a 70% pain reduction and recovery of sensory function in a patient with sensorimotor polyneuropathy.
𝑆𝑢𝑐𝑐𝑒𝑠𝑠𝑓𝑢𝑙 𝑀𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 𝑜𝑓 𝐷𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑃𝑒𝑟𝑖𝑝ℎ𝑒𝑟𝑎𝑙 𝑁𝑒𝑢𝑟𝑜𝑝𝑎𝑡ℎ𝑖𝑐 𝑃𝑎𝑖𝑛 𝑈𝑠𝑖𝑛𝑔 𝑀𝑖𝑆 𝑀𝐿𝑆® 𝐿𝑎𝑠𝑒𝑟 𝑇ℎ𝑒𝑟𝑎𝑝𝑦: 𝐴 𝐶𝑎𝑠𝑒 𝑅𝑒𝑝𝑜𝑟𝑡
Energy for Health [24], 2024
💡 On World Diabetes Day, we highlight evidence-based therapeutic options that help reduce pain, restore function, and support the clinical management of diabetes-related conditions.